291 related articles for article (PubMed ID: 12097418)
1. Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus.
Gergely P; Niland B; Gonchoroff N; Pullmann R; Phillips PE; Perl A
J Immunol; 2002 Jul; 169(2):1092-101. PubMed ID: 12097418
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus.
Gergely P; Grossman C; Niland B; Puskas F; Neupane H; Allam F; Banki K; Phillips PE; Perl A
Arthritis Rheum; 2002 Jan; 46(1):175-90. PubMed ID: 11817589
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial dysfunction in T cells of patients with systemic lupus erythematosus.
Perl A; Gergely P; Banki K
Int Rev Immunol; 2004; 23(3-4):293-313. PubMed ID: 15204090
[TBL] [Abstract][Full Text] [Related]
4. T cell activation-induced mitochondrial hyperpolarization is mediated by Ca2+- and redox-dependent production of nitric oxide.
Nagy G; Koncz A; Perl A
J Immunol; 2003 Nov; 171(10):5188-97. PubMed ID: 14607919
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide-dependent mitochondrial biogenesis generates Ca2+ signaling profile of lupus T cells.
Nagy G; Barcza M; Gonchoroff N; Phillips PE; Perl A
J Immunol; 2004 Sep; 173(6):3676-83. PubMed ID: 15356113
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis and mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus.
Perl A; Nagy G; Gergely P; Puskas F; Qian Y; Banki K
Methods Mol Med; 2004; 102():87-114. PubMed ID: 15286382
[TBL] [Abstract][Full Text] [Related]
7. Assessment of mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus.
Perl A; Hanczko R; Doherty E
Methods Mol Biol; 2012; 900():61-89. PubMed ID: 22933065
[TBL] [Abstract][Full Text] [Related]
8. Metabolic control of T cell activation and death in SLE.
Fernandez D; Perl A
Autoimmun Rev; 2009 Jan; 8(3):184-9. PubMed ID: 18722557
[TBL] [Abstract][Full Text] [Related]
9. Elevated apoptosis and impaired proliferation contribute to downregulated peripheral γ δ T cells in patients with systemic lupus erythematosus.
Lu Z; Su D; Wang D; Li X; Feng X; Sun L
Clin Dev Immunol; 2013; 2013():405395. PubMed ID: 24062776
[TBL] [Abstract][Full Text] [Related]
10. The role of nitric oxide in abnormal T cell signal transduction in systemic lupus erythematosus.
Nagy G; Perl A
Clin Immunol; 2006; 118(2-3):145-51. PubMed ID: 16406340
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand.
Georgescu L; Vakkalanka RK; Elkon KB; Crow MK
J Clin Invest; 1997 Nov; 100(10):2622-33. PubMed ID: 9366578
[TBL] [Abstract][Full Text] [Related]
12. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y
Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
[TBL] [Abstract][Full Text] [Related]
13. Cyclopentenone prostaglandins induce lymphocyte apoptosis by activating the mitochondrial apoptosis pathway independent of external death receptor signaling.
Nencioni A; Lauber K; Grünebach F; Van Parijs L; Denzlinger C; Wesselborg S; Brossart P
J Immunol; 2003 Nov; 171(10):5148-56. PubMed ID: 14607914
[TBL] [Abstract][Full Text] [Related]
14. T- and B-cell abnormalities in systemic lupus erythematosus.
Nagy G; Koncz A; Perl A
Crit Rev Immunol; 2005; 25(2):123-40. PubMed ID: 15952933
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of CD30 on CD3 T lymphocytes in patients with systemic lupus erythematosus.
Cabrera CM; Urra JM; Carreño A; Zamorano J
Scand J Immunol; 2013 Sep; 78(3):306-12. PubMed ID: 23790231
[TBL] [Abstract][Full Text] [Related]
16. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys.
Crispín JC; Oukka M; Bayliss G; Cohen RA; Van Beek CA; Stillman IE; Kyttaris VC; Juang YT; Tsokos GC
J Immunol; 2008 Dec; 181(12):8761-6. PubMed ID: 19050297
[TBL] [Abstract][Full Text] [Related]
17. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
[TBL] [Abstract][Full Text] [Related]
18. Increased mitochondrial electron transport chain activity at complex I is regulated by N-acetylcysteine in lymphocytes of patients with systemic lupus erythematosus.
Doherty E; Oaks Z; Perl A
Antioxid Redox Signal; 2014 Jul; 21(1):56-65. PubMed ID: 24673154
[TBL] [Abstract][Full Text] [Related]
19. Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosus.
Filaci G; Bacilieri S; Fravega M; Monetti M; Contini P; Ghio M; Setti M; Puppo F; Indiveri F
J Immunol; 2001 May; 166(10):6452-7. PubMed ID: 11342672
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Su DL; Wang HJ; Ji XH; Li YY; Xuan HB; Heng C; Li YF
Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
